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A ‘big’ frog (Rana esculenta) neurophysin, encompassing sequences homologous to mammalian MSEL-neurophysin and 
copeptin, has been passed through a trypsin-Sepharose column in order to compare its conformation with that of the 
two-domain intermediate precursor isolated from guinea pig. Whereas the polypeptide possesses 8 arginine residues. only 
two cleavages were observed located in a putative inter-domain sequence (at Arg-94 and Arg-I 14). Because free vasotocin 
has been isolated from the frog, it is assumed that pro-vasotocin has a three-domain conformation similar to that of 
pro-vasopressin but processing in amphibians involves only one step rather than two steps as in mammals. 
Two-domain big neurophysin; Conformation-limited proteolysis; Provasotocin-neurophysin processing; Evolution; 
(Amphibian neurophysin) 
1. INTRODUCTION 
Mammalian vasopressin is derived from a three- 
domain protein precursor processed into 
vasopressin, MSEL-neurophysin and copeptin 
during axonal transport from hypothalamus to 
neurohypophysis (review [ 1,2]). In mammals two 
types of neurophysins, MSEL-neurophysin 
(associated to vasopressin) and VLDV- 
neurophysin (associated to oxytocin) have been 
distinguished [1,3]. In non-mammalian tetrapods, 
vasopressin and oxytocin are replaced by vasotocin 
and mesotocin, respectively [l], and because the 
two types of neurophysins have been identified in 
birds [4,5], it has been assumed that vasotocin and 
mesotocin protein precursors are built in the same 
way as their mammalian counterparts [l]. This 
view has been substantiated for the Japanese toad 
Bufojaponicus by cDNA prediction [6] and for the 
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European frog Rana esculenta by direct protein se- 
quencing [7]. In particular a ‘big’ neurophysin en- 
compassing sequences homologous to mammalian 
MSEL-neurophysin and copeptin has been iden- 
tified in the frog [7]. This big neurophysin 
therefore resembles the intermediate neurophysin- 
copeptin precursor characterized in guinea pig 
[8,9]. On the other hand this protein displays close 
homology with the vasotocin-linked neurophysin 
of Japanese toad [6]. 
Whereas in mammals complete processing of the 
vasopressin precursor usually involves two en- 
zymic cleavages at a dibasic and a monobasic site, 
respectively, in amphibians a single cleavage of the 
vasotocin precursor at the dibasic site gives the 
hormone and a fragment spanning neurophysin 
and copeptin. Conformation-limited proteolysis of 
the guinea pig intermediate precursor by im- 
mobilized trypsin has revealed cleavages only in 
the inter-domain region [9]. The frog big 
neurophysin has now been passed through a col- 
umn of trypsin-Sepharose in order to compare it 
with the mammalian intermediate precursor and to 
check whether a change of conformation might ex- 
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plain the lack of a second cleavage in the amphi- 
bian precursor processing. 
2. MATERIALS AND METHODS 
Frog big MSEL-neurophysin has been purified as previously 
described [7]. A column (0.3 x 25 cm) of trypsin-Sepharose 4B, 
prepared in order to contain 5 nmol of trypsin per ml [9], buf- 
fered with 0.05 M phosphate, pH 7.4, has been used. The 
passage of frog neurophysin (0.065 mg in 0.2 ml) was carried 
out for 3 min at room temperature (23°C). The effluent is con- 
centrated to a small volume. Half has been used for control 
through high-pressure reverse-phase liquid chromatography 
[lo]. The remainder has been subjected to microsequencing in 
an Applied Biosystems 470 A gas-phase microsequencer under 
conditions described [8,9]. Because complete sequence of the 
frog big neurophysin has been established [7], peptide bonds en- 
zymatically cleaved in the protein could be located by determin- 
ing new N-terminal sequences that appeared after contact with 
the proteolytic enzyme. 
3. RESULTS AND DISCUSSION 
Table 1 gives the results of the Edman degrada- 
tion carried out in the sequencer on the tryptic pro- 
ducts. Three amino acid sequences can be 
recognized. The first (7 residues) corresponds to 
the N-terminal sequence of the amphibian MSEL- 
neurophysin. The second sequence (7 residues) 
shows that cleavage has occurred at the 
Arg-94-Val-95 bond (fig. 1). The third sequence (6 
residues) reveals a cleavage at the level of the 
Arg-114-Leu-115 bond (fig.1). Of the 8 arginyl 
bonds present in amphibian neurophysin and 
susceptible to trypsin, only two have apparently 
been split by trypsin-Sepharose. These bonds are 
located in an inter-domain region. 
Comparison of amino acid sequences between 
ox MSEL-neurophysin-copeptin and frog big 
MSEL-neurophysin does not reveal a clear varia- 
tion explaining the difference in the processings. 
Substitution of one in the arginine pairs located in 
ante-penultimate position of the cleavage-specific 
residue has already been observed in rat [l l] 
without modification in processing. A variation in 
conformation of the intermediate precursor may 
explain the lack of the second cleavage. Frog 
MSEL-neurophysin possesses two putative sites 
for glycosylation, one at position 100 (Asn-Met- 
Thr) and another at position 105 (Asn-Gly-Ser). 
Because the protein is bound to concanavalin A- 
Sepharose, at least one of them, probably 
Asn-105, is actually glycosylated. A change in 
location of the carbohydrate (in ox the car- 
bohydrate is located 6 residues downstream the 
specific bond instead of 11 in frog) or in its struc- 
ture might make a steric hindrance for the process- 
ing enzyme but not for trypsin. Another 
explanation for the lack of the second cleavage 
could be a difference in the specific processing en- 
zyme or its absence. 
It is of interest to note that neurophysins with 
apparent molecular masses of about 20 kDa have 
been detected in other amphibians uch as Rana pi- 
piens [12], Rana temporaria [13], Bufo bufo [14], 
Table 1 
Amino acid sequences of amphibian neurophysin fragments given by trypsin-Sepharose 
Sequencing 
cycle 
1st sequence 2nd sequence 3rd sequence 
Noresidue in Nature of pm01 No.residue in Nature of pm01 No.residue in Nature of pm01 
the protein the residue the protein the residue the protein the residue 
1 1 Ser” 100 95 Val 358 
2 2 Tyr 330 96 Sera de- 
tected 
3 3 Pro (65Qb 97 Pro (658)b 
4 4 Asp (520)b 98 Asp (520)b 
5 5 Thr 200 99 Gln 
6 6 Glu 120 100 Asn (E)b 
7 7 Val 250 101 Met 100 
a Ser derivative is unstable and value is low 
b The same residue being present in two sequences (fig.l), the value given is cumulative 
115 Leu 300 
116 Met 180 
117 His 100 
118 Met 150 
119 Ala 160 
120 Asn (119)b 
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Frog 
OX 
Frog 
OX 
Frog 
OX 
Frog 
OX 
Frog 
OX 
Frog 
OX 
1 5 10 15 20 25 
Ser-Tyr-Pro-ASp-Thr-Gl"-Val-Arg-Gln-CyS-Ile-Pro-Cys-Gly-Pro-Gly-Asn-Arg-Gly-Asn-Cys-Phe-Gly-Pro-A~n 
Ala-Met-Ser-Leu- Le" Le" Gly-Lys - Arg Ser 
26 30 35 40 45 50 
Ile-Cys-Cys-Gly-Gl"-Asp-Le"-Gly~ys~yr-Ile-Gly~hr-Pro-Glu-Thr-~u-Arg-Cys-Val-Glu-Glu-A~n-Tyr-Le" 
Asp-Gl" Phe-val- Ala - Ala Gill 
50 55 60 65 70 75 
Pro-Ser-Pro-Cys-Gl"-Ala-Gly-Gly-Lys-Pro-Cys-Gly-Ala-Gly-Gly-Arg-Cys-Ala-Ala-Pro-Gly-Val-Cys-Cys-Asn 
Gln-Ser - Gln Ser Ala - Ile -~ 
Neurophysin domai T 
75 80 85 90 +--I v95 100 
ASp-Gln-Ser-CyS-Thr~Met-Asp-Ser-Ser~ys-Le"-Asp~lu-Asp-Ser~lu-Arg-Gln-Arg-Val-Ser-Pro-Asp-Gln-Asn 
- Glu- Val-Thr-Glu-Pro-Gl" - Arg-Glu-Gly-$iP-Gly-Phe/\ Val -fiAla-Asn-ASp-Arg-Ser - 
PI-/o-kg Q 
T 
101 105 110 i 8 ll5 120 125 
Met-Thr-Gln-Met-ASn~ly-Ser-Ala-Ser-Asp-~u-~"-~u-Arg~Le"-Met-His-M~t-Al~-Asn-Arg-Gln-Gln-Gln-Gln 
Ala - Leu-Leu-Asp - Pro-Ser-Gly-Ala Val-Gln-Leu - Gly-Ala-Pro-Glu-Pro-Ala 
126 129 133 
Thr-Lys-His-Tyr 
Glu-Pro-Ala-Gln-Pro-Gly-Val-Tyr 
Fig.1. Comparison of amino acid sequences of amphibian big MSEL-neurophysin and bovine MSEL-neurophysin/copeptin. Frog 
numbering is used and a two-residue insertion (Pro-Arg) is assumed in ox protein for maximalizing homology. Residues identical to 
those of the frog protein are indicated by solid lines. T, trypsin-Sepharose cleavages in frog big neurophysin; E, processing 
endopeptidase cleavage in ox neurophysin/copeptin precursor. 
Bufo ictericus [ 141 and Xenopus laevis [ 14,151 
along with mesotocin and vasotocin [ 16-191. The 
one-step processing therefore seems rather general 
in amphibians. 
The transition of non-mammals to mammals is 
apparently accompanied not only by the replace- 
ment of vasotocin with vasopressin, which can be 
explained by a single mutation in the first codon of 
the mammalian gene [20-221, but also by the ap- 
pearance of a second cleavage in the precursor, 
which could involve a variation in the third exon 
encoding the second processing site. Evolution of 
processing may be a composite phenomenon as is 
evolution of a precursor protein encoded by a 
three-exon gene [23]. 
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